Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Eosinophilic Esophagitis | 7 | 2019 | 18 | 3.660 |
Why?
|
Gastroesophageal Reflux | 8 | 2017 | 117 | 1.890 |
Why?
|
Proton Pump Inhibitors | 5 | 2019 | 31 | 1.440 |
Why?
|
Deglutition Disorders | 5 | 2024 | 115 | 1.340 |
Why?
|
Peptic Ulcer | 2 | 2019 | 19 | 1.330 |
Why?
|
Esophageal Achalasia | 4 | 2020 | 57 | 1.120 |
Why?
|
Esophageal Sphincter, Lower | 4 | 2024 | 32 | 1.110 |
Why?
|
Monitoring, Ambulatory | 2 | 2016 | 32 | 1.010 |
Why?
|
Esophageal pH Monitoring | 5 | 2016 | 12 | 0.910 |
Why?
|
Anti-Bacterial Agents | 2 | 2019 | 739 | 0.880 |
Why?
|
Budesonide | 2 | 2019 | 44 | 0.850 |
Why?
|
Esophagoscopy | 3 | 2018 | 87 | 0.810 |
Why?
|
Esophagus | 4 | 2016 | 102 | 0.790 |
Why?
|
Dilatation | 3 | 2016 | 46 | 0.780 |
Why?
|
Helicobacter Infections | 2 | 2019 | 34 | 0.760 |
Why?
|
Helicobacter pylori | 2 | 2019 | 35 | 0.760 |
Why?
|
Esophagitis | 2 | 2016 | 42 | 0.690 |
Why?
|
Esophageal Stenosis | 2 | 2015 | 26 | 0.640 |
Why?
|
Anti-Ulcer Agents | 1 | 2018 | 22 | 0.640 |
Why?
|
Laryngopharyngeal Reflux | 1 | 2017 | 2 | 0.640 |
Why?
|
Malus | 1 | 2017 | 3 | 0.630 |
Why?
|
Weight Loss | 2 | 2016 | 229 | 0.590 |
Why?
|
Esophageal Mucosa | 1 | 2016 | 4 | 0.590 |
Why?
|
Cough | 2 | 2016 | 53 | 0.580 |
Why?
|
Mediastinal Diseases | 1 | 2016 | 21 | 0.570 |
Why?
|
Telemetry | 1 | 2016 | 38 | 0.570 |
Why?
|
Granuloma | 1 | 2016 | 65 | 0.560 |
Why?
|
Enteropathy-Associated T-Cell Lymphoma | 1 | 2015 | 2 | 0.540 |
Why?
|
Consensus | 1 | 2017 | 333 | 0.530 |
Why?
|
Intestinal Neoplasms | 1 | 2015 | 56 | 0.510 |
Why?
|
Diarrhea | 1 | 2015 | 181 | 0.490 |
Why?
|
Fluticasone | 4 | 2019 | 30 | 0.460 |
Why?
|
Decision Trees | 1 | 2012 | 63 | 0.440 |
Why?
|
Costs and Cost Analysis | 1 | 2012 | 153 | 0.420 |
Why?
|
Manometry | 4 | 2024 | 43 | 0.410 |
Why?
|
Practice Guidelines as Topic | 2 | 2017 | 1030 | 0.400 |
Why?
|
Humans | 31 | 2024 | 86281 | 0.400 |
Why?
|
Endoscopy, Digestive System | 3 | 2016 | 65 | 0.360 |
Why?
|
Fundoplication | 4 | 2017 | 72 | 0.350 |
Why?
|
Portasystemic Shunt, Surgical | 1 | 2008 | 12 | 0.330 |
Why?
|
Hyperammonemia | 1 | 2008 | 10 | 0.330 |
Why?
|
Brain Edema | 1 | 2008 | 50 | 0.320 |
Why?
|
Steroids | 2 | 2019 | 172 | 0.320 |
Why?
|
Gastrointestinal Agents | 2 | 2018 | 161 | 0.290 |
Why?
|
Adult | 14 | 2020 | 25577 | 0.280 |
Why?
|
Electric Impedance | 3 | 2016 | 104 | 0.280 |
Why?
|
Liver Cirrhosis | 1 | 2008 | 296 | 0.270 |
Why?
|
Precancerous Conditions | 1 | 2006 | 196 | 0.260 |
Why?
|
Pharmacogenetics | 2 | 2019 | 434 | 0.260 |
Why?
|
Glucocorticoids | 2 | 2018 | 347 | 0.250 |
Why?
|
Esophageal Motility Disorders | 1 | 2024 | 12 | 0.240 |
Why?
|
Single-Blind Method | 2 | 2015 | 151 | 0.240 |
Why?
|
Cannabis | 1 | 2024 | 33 | 0.240 |
Why?
|
Prospective Studies | 5 | 2016 | 4194 | 0.230 |
Why?
|
Male | 16 | 2020 | 40860 | 0.230 |
Why?
|
Predictive Value of Tests | 3 | 2016 | 1671 | 0.210 |
Why?
|
Female | 16 | 2020 | 44405 | 0.210 |
Why?
|
Hospitalization | 2 | 2020 | 844 | 0.200 |
Why?
|
Disease Management | 2 | 2020 | 327 | 0.200 |
Why?
|
Peristalsis | 1 | 2020 | 10 | 0.190 |
Why?
|
Treatment Outcome | 7 | 2018 | 7949 | 0.190 |
Why?
|
Middle Aged | 13 | 2020 | 24957 | 0.190 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2006 | 546 | 0.180 |
Why?
|
Colonoscopy | 2 | 2015 | 260 | 0.180 |
Why?
|
Colectomy | 1 | 2020 | 166 | 0.170 |
Why?
|
Sleep Wake Disorders | 1 | 2020 | 115 | 0.170 |
Why?
|
Interleukin-13 | 1 | 2019 | 36 | 0.170 |
Why?
|
Colorectal Neoplasms | 1 | 2006 | 924 | 0.170 |
Why?
|
Prescription Drugs | 1 | 2019 | 36 | 0.170 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2016 | 493 | 0.160 |
Why?
|
Reproducibility of Results | 2 | 2016 | 2699 | 0.160 |
Why?
|
Proton Pumps | 1 | 2017 | 4 | 0.160 |
Why?
|
Americas | 1 | 2017 | 19 | 0.160 |
Why?
|
Hypopharynx | 1 | 2017 | 8 | 0.160 |
Why?
|
Longitudinal Studies | 3 | 2016 | 1015 | 0.160 |
Why?
|
Diet, Mediterranean | 1 | 2017 | 6 | 0.160 |
Why?
|
Drug Prescriptions | 1 | 2019 | 141 | 0.150 |
Why?
|
Asia | 1 | 2017 | 94 | 0.150 |
Why?
|
Climate | 1 | 2017 | 50 | 0.150 |
Why?
|
Barrett Esophagus | 1 | 2018 | 93 | 0.150 |
Why?
|
Laparoscopy | 4 | 2017 | 746 | 0.150 |
Why?
|
Severity of Illness Index | 2 | 2020 | 1796 | 0.150 |
Why?
|
Europe | 1 | 2017 | 308 | 0.150 |
Why?
|
Hoarseness | 1 | 2016 | 11 | 0.140 |
Why?
|
Biological Products | 1 | 2019 | 143 | 0.140 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 241 | 0.140 |
Why?
|
Itraconazole | 1 | 2016 | 11 | 0.140 |
Why?
|
Transducers | 1 | 2016 | 41 | 0.140 |
Why?
|
Clinical Decision-Making | 1 | 2019 | 255 | 0.140 |
Why?
|
Attitude to Health | 1 | 2018 | 220 | 0.140 |
Why?
|
Food, Formulated | 1 | 2016 | 24 | 0.140 |
Why?
|
Respiratory Sounds | 1 | 2016 | 33 | 0.140 |
Why?
|
Urban Population | 1 | 2017 | 213 | 0.140 |
Why?
|
Catheters | 1 | 2016 | 68 | 0.140 |
Why?
|
Hypersensitivity | 1 | 2017 | 153 | 0.140 |
Why?
|
Mucous Membrane | 2 | 2014 | 83 | 0.140 |
Why?
|
Dexlansoprazole | 1 | 2015 | 1 | 0.140 |
Why?
|
Esophagoplasty | 1 | 2015 | 10 | 0.140 |
Why?
|
Antifungal Agents | 1 | 2016 | 117 | 0.130 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 237 | 0.130 |
Why?
|
Aged | 7 | 2020 | 18353 | 0.130 |
Why?
|
Esophageal Neoplasms | 1 | 2018 | 320 | 0.130 |
Why?
|
Food Hypersensitivity | 1 | 2016 | 63 | 0.130 |
Why?
|
Adrenal Cortex Hormones | 1 | 2016 | 263 | 0.130 |
Why?
|
Diagnosis, Differential | 2 | 2016 | 1562 | 0.120 |
Why?
|
Sex Factors | 1 | 2017 | 1053 | 0.120 |
Why?
|
Genome, Human | 1 | 2019 | 756 | 0.120 |
Why?
|
Crohn Disease | 1 | 2020 | 729 | 0.120 |
Why?
|
Hernia, Hiatal | 1 | 2013 | 30 | 0.110 |
Why?
|
Tennessee | 1 | 2012 | 17 | 0.110 |
Why?
|
Age Factors | 1 | 2017 | 1842 | 0.110 |
Why?
|
Oliguria | 1 | 2012 | 5 | 0.110 |
Why?
|
Acoustics | 1 | 2012 | 51 | 0.110 |
Why?
|
Antibodies, Monoclonal | 1 | 2019 | 1376 | 0.110 |
Why?
|
Patient Selection | 1 | 2016 | 685 | 0.110 |
Why?
|
Metered Dose Inhalers | 1 | 2012 | 33 | 0.110 |
Why?
|
Urinary Bladder Diseases | 1 | 2012 | 37 | 0.110 |
Why?
|
Androstadienes | 1 | 2012 | 72 | 0.110 |
Why?
|
Ascites | 1 | 2012 | 55 | 0.110 |
Why?
|
Biopsy | 1 | 2015 | 1160 | 0.100 |
Why?
|
Creatinine | 1 | 2012 | 337 | 0.100 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2012 | 152 | 0.100 |
Why?
|
Self Report | 1 | 2012 | 287 | 0.100 |
Why?
|
Immunohistochemistry | 1 | 2015 | 1752 | 0.100 |
Why?
|
Young Adult | 3 | 2020 | 5961 | 0.100 |
Why?
|
Adenocarcinoma | 1 | 2018 | 1160 | 0.100 |
Why?
|
Urinary Bladder | 1 | 2012 | 236 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2012 | 339 | 0.090 |
Why?
|
Research Design | 1 | 2012 | 594 | 0.080 |
Why?
|
Logistic Models | 1 | 2012 | 1184 | 0.080 |
Why?
|
Disease Progression | 2 | 2018 | 1531 | 0.080 |
Why?
|
Pharmacogenomic Testing | 2 | 2019 | 97 | 0.080 |
Why?
|
Risk Factors | 3 | 2020 | 5397 | 0.080 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 1610 | 0.080 |
Why?
|
Biomarkers, Tumor | 1 | 2015 | 1461 | 0.070 |
Why?
|
Retrospective Studies | 3 | 2024 | 8431 | 0.070 |
Why?
|
Population Surveillance | 1 | 2006 | 219 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 2594 | 0.060 |
Why?
|
Biomarkers | 2 | 2012 | 1709 | 0.060 |
Why?
|
Precision Medicine | 2 | 2019 | 394 | 0.060 |
Why?
|
Dronabinol | 1 | 2024 | 53 | 0.060 |
Why?
|
Recurrence | 2 | 2016 | 1137 | 0.060 |
Why?
|
Surveys and Questionnaires | 2 | 2019 | 2495 | 0.050 |
Why?
|
Drug Recalls | 1 | 2019 | 13 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2016 | 3616 | 0.040 |
Why?
|
Esomeprazole | 1 | 2018 | 2 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2020 | 6481 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 859 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 857 | 0.040 |
Why?
|
Point-of-Care Systems | 1 | 2019 | 141 | 0.040 |
Why?
|
Prednisone | 1 | 2018 | 255 | 0.040 |
Why?
|
Guidelines as Topic | 1 | 2019 | 162 | 0.040 |
Why?
|
Research | 1 | 2019 | 253 | 0.040 |
Why?
|
Perception | 1 | 2018 | 167 | 0.040 |
Why?
|
Adolescent | 2 | 2020 | 8968 | 0.040 |
Why?
|
Health Personnel | 1 | 2019 | 202 | 0.040 |
Why?
|
Remission Induction | 1 | 2018 | 722 | 0.040 |
Why?
|
Dilatation, Pathologic | 1 | 2016 | 54 | 0.040 |
Why?
|
Italy | 1 | 2016 | 106 | 0.040 |
Why?
|
Sleep | 1 | 2020 | 440 | 0.040 |
Why?
|
Digestive System Surgical Procedures | 1 | 2017 | 120 | 0.030 |
Why?
|
Communication | 1 | 2019 | 438 | 0.030 |
Why?
|
Illinois | 1 | 2016 | 461 | 0.030 |
Why?
|
Patient Care Team | 1 | 2017 | 280 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 850 | 0.030 |
Why?
|
Physician-Patient Relations | 1 | 2019 | 610 | 0.030 |
Why?
|
Body Mass Index | 1 | 2016 | 770 | 0.030 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2018 | 929 | 0.030 |
Why?
|
Prognosis | 1 | 2020 | 3669 | 0.030 |
Why?
|
Rupture | 1 | 2012 | 62 | 0.030 |
Why?
|
Infant | 1 | 2018 | 3036 | 0.030 |
Why?
|
Wounds, Nonpenetrating | 1 | 2012 | 92 | 0.030 |
Why?
|
Child, Preschool | 1 | 2018 | 3608 | 0.030 |
Why?
|
Risk Assessment | 1 | 2018 | 2253 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2012 | 264 | 0.020 |
Why?
|
Child | 1 | 2018 | 6913 | 0.020 |
Why?
|